
EORTC/X
Mar 15, 2025, 03:26
The use of machine learning to characterise the tumour-immune microenvironment – EORTC
EORTC – European Organisation for Research and Treatment of Cancer shared a post on LinkedIn:
“New advancements in breast cancer research!
Our latest publication explores the use of machine learning to characterise the tumour-immune microenvironment in the EORTC 10994/BIG 1-00 trial.
Discover how AI is helping us understand immune infiltrates and their prognostic implications.
Read more.”
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial.
Authors: Ioannis Zerdes, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 14, 2025, 17:49
Mar 14, 2025, 17:30
Mar 14, 2025, 16:09
Mar 14, 2025, 15:41